Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthesis

2-Aminothiazoles Are Problematic Frequent Hitters In Drug Discovery Assays

Researchers suggest removing promiscuous 2-aminothiazoles from compound libraries used for fragment-based drug discovery

by Celia Henry Arnaud
January 19, 2015 | A version of this story appeared in Volume 93, Issue 3

2-Aminothiazoles (2-ATs) frequently show up as hits in drug discovery assays, but molecules containing this group prove difficult to optimize into lead compounds. The most promiscuous 2-ATs, which have been dubbed PrATs, are particularly problematic when it comes to fragment-based drug discovery, according to Martin J. Scanlon of Monash Institute of Pharmaceutical Sciences, in Australia, and coworkers there and at AstraZeneca, in Macclesfield, England (J. Med. Chem. 2015, DOI: 10.1021/jm501402x). In previous work, at least one 2-AT in Monash’s fragment library showed up as a hit in 14 different screening campaigns that used nuclear magnetic resonance for readout detection. The researchers therefore decided to characterize the binding of all 2-ATs in the fragment library against six protein targets using surface plasmon resonance. In this second set of screens, the same particularly promiscuous member of the class—4-phenylthiazol-2-amine—gave positive results in all six assays. Several other 2-ATs bind at least five of the targets. In addition, no clear structure-activity relationships emerged from analysis of binding of a panel of 2-ATs to the targets. Although a number of known drugs contain a 2-AT group, developing a weakly binding 2-AT fragment into a potent and selective compound appears to be particularly challenging. The researchers advise eliminating them from screening libraries for fragment-based drug discovery.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.